Stanozolol 50 - Ice Pharmaceuticals

Not all anabolic steroids were built for broad hormonal replacement-Stanozolol was engineered to deliver high anabolic efficiency with minimal androgenic consequences. Marketed as Winstrol beginning in 1962, it served patients with wasting diseases and hormonal deficiencies. Its structure avoided aromatization, which meant no water retention or gynecomastia. While U.S. approval narrowed over time, other countries continued production. Veterinary applications, particularly in equine performance, helped preserve the drug’s legacy despite its restricted human use in several markets.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 50 by Ice Pharmaceuticals, consult with your doctor or healthcare professional.